Goals of treatment for patients with metastatic breast cancer

Seminars in Oncology

Volumn 33, Issue SUPPL. 2, 2006, Pages 2-

  Smith, Ian ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; ANTHRACYCLINE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CLODRONIC ACID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN; EXEMESTANE; FLUOROURACIL; FULVESTRANT; GEMCITABINE; GESTAGEN; GOSERELIN; LETROZOLE; METHOTREXATE; MITOMYCIN; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; TAMOXIFEN; TOREMIFENE; TRASTUZUMAB; UNINDEXED DRUG; VINBLASTINE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DISEASE FREE SURVIVAL; DYSPNEA; HUMAN; LUNG CANCER; METASTASIS; MONOTHERAPY; MOOD DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; THERAPY DELAY; TREATMENT FAILURE; TREATMENT RESPONSE; VALIDATION PROCESS;

EID: 32044461321     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. J. O'Shaughnessy, D. Miles, S. Vukelja Superior survival with capecitabine plus docetaxel combination chemotherapy in anthracycline-pretreated patients with advanced breast cancer phase 3 trial results J Clin Oncol 20 2002 2812 2833
2. J. Jassem, T. Pienkowski, A. Pluzanska Doxorubicin and paclitaxel vs fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with metastatic breast cancer Final results of a randomised phase III multicentre trial J Clin Oncol 19 2001 1707 1715
3. D.J. Stewart, W.K. Evans, F.A. Shepherd Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer Superiority of doxorubicin J Clin Oncol 15 1997 1897 1905
4. J.F. Bishop, J. Dewar, G.C. Toner Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer J Clin Oncol 17 1999 2355 2364
5. J.M. Nabholtz, H.J. Senn, E.R. Bezwoda Prospective randomised trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy J Clin Oncol 17 1999 1413 1424
6. K. Albain, S. Nag, G. Calderillo-Ruiz Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC) First report of overall survival Proc Am Soc Clin Oncol 22 2004 5 (abstr 510)
7. H. Mouridsen, M. Gershanovich, Y. Sun Superior efficacy of letrozole versus tamoxifen as first-line therapy for menopausal women with advanced breast cancer Results of a phase III study of the International Letrozole Breast Cancer Group J Clin Oncol 19 2001 2596 2606
8. H. Mouridsen, Y. Sun, M. Gershanovich Final survival analysis of the double-blind, randomised multinational phase III trial of letrozole (Femara) compared to tamoxifen as first-line hormonal therapy for advanced breast cancer Breast Cancer Res Treat 69 2001 211 (abstr 9)
9. D.J. Slamon, B. Leyland-Jones, S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 791
10. P. Geels, E. Eisenhauer, A. Bezjak Palliative effect of chemotherapy Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer J Clin Oncol 18 2000 2395 2405
11. D.F. Cella, D.S. Tulsky, G. Gray The Functional Assessment of Cancer Therapy scale Development and validation of the general measure J Clin Oncol 11 1993 570 579
12. N.K. Aaronson, S. Ahmedzai, B. Bergman The European Organisation for Research and Treatment of Cancer QLQ-C30 A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
13. A.S. Coates, C. Hurny, H.F. Peterson Quality of Life Scores predict outcome in metastatic but not in early breast cancer J Clin Oncol 18 2000 3768 3774
14. P.J. Goodwin, J.T. Black, J. Bordeleau Health-related quality of life measurement in randomised clinical trials in breast cancer-taking stock J Natl Cancer Inst 95 2003 263 281
15. A. Bottomley, P. Therasse Quality of life in patients undergoing systemic therapy for advanced breast cancer Lancet Oncol 3 2003 620 628
16. J.A. Kramer, D. Curran, M. Piccart Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer Quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist Eur J Cancer 36 2000 1488 1497